Cite
HARVARD Citation
Poordad, F. et al. (n.d.). Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients with Advanced Cirrhosis or Post‐transplant Recurrence: Final Results of the ALLY‐1 Study: 2016 ACG Presidential Poster Award. American journal of gastroenterology. p. . [Online].